Detailed Mechanism Funding and Narrative

Years of mechanism: 2012 2013 2014 2015 2016 2017 2018 2019 2020

Details for Mechanism ID: 14441
Country/Region: Malawi
Year: 2016
Main Partner: Lighthouse Trust
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: HHS/CDC
Total Funding: $4,700,000 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $773,360
Care: TB/HIV (HVTB) $264,920
Care: Pediatric Care and Support (PDCS) $11,520
Health Systems Strengthening (OHSS) $60,000
Testing: HIV Testing and Counseling (HVCT) $199,300
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $93,500
Treatment: Adult Treatment (HTXS) $2,752,720
Treatment: Pediatric Treatment (PDTX) $544,680
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Age/sex: <1 2017 8,762
HTS_TST Age/sex: 1-9 2017 69,932
HTS_TST Age/sex: 10-14 Female 2017 15,231
HTS_TST Age/sex: 10-14 Male 2017 14,770
HTS_TST Age/sex: 15-19 Female 2017 12,737
HTS_TST Age/sex: 15-19 Male 2017 12,191
HTS_TST Age/sex: 20-24 Female 2017 10,699
HTS_TST Age/sex: 20-24 Male 2017 10,138
HTS_TST Age/sex: 25-49 Female 2017 30,905
HTS_TST Age/sex: 25-49 Male 2017 28,932
HTS_TST Age/sex: 50+ Female 2017 10,680
HTS_TST Age/sex: 50+ Male 2017 9,279
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 54,362
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 54,334
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 65,019
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 60,541
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 234,256
HTS_TST Service Delivery Point (Facility): Inpatient 2017 15,226
HTS_TST Service Delivery Point (Facility): Other PITC 2017 66,528
HTS_TST Service Delivery Point (Facility): Pediatric 2017 41,464
HTS_TST Service Delivery Point (Facility): PMTCT 2017 66,528
HTS_TST Service Delivery Point (Facility): TB Clinics 2017 2,110
HTS_TST Service Delivery Point (Facility): VCT 2017 42,400
HTS_TST Sum of Age/Sex disaggregates 2017 155,562
HTS_TST Sum of Aggregated Age/Sex <15 2017 108,696
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 125,560
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 234,256
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Female 2017 246
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Male 2017 238
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Female 2017 1,371
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Male 2017 1,311
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Female 2017 1,151
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Male 2017 1,093
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Female 2017 3,330
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Male 2017 3,117
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Female 2017 1,150
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Male 2017 1,000
HTS_TST_POS Test Result by Age: Positive: <1 2017 141
HTS_TST_POS Test Result by Age: Positive: 1-9 2017 1,132
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 879
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 878
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 7,004
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 6,523
PMTCT_ART Already on ART at beginning of current pregnancy 2017 2,949
PMTCT_ART New on ART 2017 2,723
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 55,672
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 1,546
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2017 2,632
PMTCT_EID Number of infants with a positive virological test result within 12 months of birth 2017 77
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2017 43
PMTCT_EID Sum of Infant Age disaggregates 2017 4,178
PMTCT_STAT By Age (DREAMS SNUs ONLY): <15 2017 157
PMTCT_STAT By Age (DREAMS SNUs ONLY): 15-19 2017 11,758
PMTCT_STAT By Age (DREAMS SNUs ONLY): 20-24 2017 18,655
PMTCT_STAT By Age (DREAMS SNUs ONLY): 25-49 2017 18,655
PMTCT_STAT By Age (DREAMS SNUs ONLY): 50+ 2017 6,447
PMTCT_STAT By: Known positives at entry 2017 3,223
PMTCT_STAT By: Number of new positives identified 2017 2,746
PMTCT_STAT Number of new ANC and L&D clients 2017 58,601
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 55,672
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: <15 2017 681
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 15-19 2017 8
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 20-24 2017 1,080
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 25-49 2017 1,081
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 50+ 2017 373
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: <15 2017 7
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 15-19 2017 578
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 20-24 2017 921
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 25-49 2017 921
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 50+ 2017 319
PMTCT_STAT Sum of Positives Status disaggregates 2017 5,969
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: <15 2017 165
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: <15-19 2017 12,378
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: 20-24 2017 19,637
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: 25-49 2017 19,636
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: 50+ 2017 6,785
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 45
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 649
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 24
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 357
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 1,221
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 1,075
TB_SCREENDX [Sub-Disagg of Screen Result] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 37,069
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: other (not Xpert) 2017 3,347
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Smear only 2017 30,325
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 3,397
TB_SCREENDX Screen Result: Screened Positive for TB 2017 507
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 30,585
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 16,892
TB_SCREENDX Screened for TB by Age/Sex:<15 Female 2017 2,083
TB_SCREENDX Screened for TB by Age/Sex:<15 Male 2017 1,150
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 50,710
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 134
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 1,955
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 72
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 1,079
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 3,240
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 3,449
TX_CURR Age/Sex: <1 2017 857
TX_CURR Age/Sex: <1-9 2017 3,761
TX_CURR Age/Sex: 10-14 Female 2017 863
TX_CURR Age/Sex: 10-14 Male 2017 788
TX_CURR Age/Sex: 15-19 Female 2017 1,760
TX_CURR Age/Sex: 15-19 Male 2017 375
TX_CURR Age/Sex: 20-24 Female 2017 5,533
TX_CURR Age/Sex: 20-24 Male 2017 626
TX_CURR Age/Sex: 25-49 Female 2017 22,271
TX_CURR Age/Sex: 25-49 Male 2017 12,449
TX_CURR Age/Sex: 50+ Female 2017 1,779
TX_CURR Age/Sex: 50+ Male 2017 2,317
TX_CURR Aggregated Age/Sex: <15 Female 2017 3,225
TX_CURR Aggregated Age/Sex: <15 Male 2017 3,041
TX_CURR Aggregated Age/Sex: 15+ Female 2017 29,710
TX_CURR Aggregated Age/Sex: 15+ Male 2017 17,403
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 53,379
TX_CURR Sum of age/sex disaggregates 2017 2,135
TX_CURR Sum of Aggregated Age/Sex <15 2017 6,266
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 47,113
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 53,379
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 838
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 789
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 6,442
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 3,575
TX_NEW By Age/Sex: <1 2017 223
TX_NEW By Age/Sex: 1-9 2017 976
TX_NEW By Age/Sex: 10-14 Female 2017 224
TX_NEW By Age/Sex: 10-14 Male 2017 205
TX_NEW By Age/Sex: 15-19 Female 2017 362
TX_NEW By Age/Sex: 15-19 Male 2017 76
TX_NEW By Age/Sex: 20-24 Female 2017 1,136
TX_NEW By Age/Sex: 20-24 Male 2017 128
TX_NEW By Age/Sex: 25-49 Female 2017 4,578
TX_NEW By Age/Sex: 25-49 Male 2017 2,894
TX_NEW By Age/Sex: 50+ Female 2017 366
TX_NEW By Age/Sex: 50+ Male 2017 476
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 11,644
TX_NEW Sum of Age/Sex disaggregates 2017 10,445
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 11,644
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 18,684
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 16,815
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 779
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 733
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 9,841
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 5,462
TX_PVLS Numerator: Indication: Routine 2017 15,133
TX_PVLS Numerator: Indication: Targeted 2017 11
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Female 2017 865
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Male 2017 818
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 10,933
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 6,068
TX_PVLS_den Denominator: Indication: Routine 2017 16,815
TX_PVLS_den Denominator: Indication: Targeted 2017 11
TX_RET Age/Sex: <1 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 129
TX_RET Age/Sex: 1-9 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 565
TX_RET Age/Sex: 10-14 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 129
TX_RET Age/Sex: 10-14 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 117
TX_RET Age/Sex: 15-19 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 395
TX_RET Age/Sex: 15-19 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 83
TX_RET Age/Sex: 20-24 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,243
TX_RET Age/Sex: 20-24 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 140
TX_RET Age/Sex: 25-49 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 5,001
TX_RET Age/Sex: 25-49 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 3,163
TX_RET Age/Sex: 50+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 399
TX_RET Age/Sex: 50+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 520
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 482
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 457
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 7,037
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 3,908
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 11,884
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 13,059
TX_RET_den Age/Sex: >1 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 142
TX_RET_den Age/Sex: 1-9 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 620
TX_RET_den Age/Sex: 10-14 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 142
TX_RET_den Age/Sex: 10-14 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 129
TX_RET_den Age/Sex: 15-19 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 432
TX_RET_den Age/Sex: 15-19 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 94
TX_RET_den Age/Sex: 20-24 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,368
TX_RET_den Age/Sex: 20-24 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 155
TX_RET_den Age/Sex: 25-49 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 5,490
TX_RET_den Age/Sex: 25-49 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 3,476
TX_RET_den Age/Sex: 50+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 438
TX_RET_den Age/Sex: 50+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 573
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 531
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 502
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 7,733
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 4,293
Cross Cutting Budget Categories and Known Amounts Total: $128,000
Food and Nutrition: Commodities $8,000
Human Resources for Health $60,000
Key Populations: Sex Workers $10,000
Implementation of core HIV prevention interventions for SWs consistent with PEPFAR guidance on sexual prevention
Renovation $50,000